Integra Lifesciences 

€19.8
5
+€0+0% Friday 06:06

統計

當日最高
19.8
當日最低
19.8
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
1.65B
市盈率
69.85
股息收益率
-
股息
-

即將到來

收益

23Oct確認
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0.47
0.62
0.76
0.9
預期每股收益
0.472816
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 IL3.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

26.29平均價格目標
最高估價為 €35。
來自過去 6 個月內的 7 個評級。這不是投資建議。
買入
0%
持有
43%
賣出
57%

關於

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Show more...
首席執行官
Dr. Stuart M. Essig Ph.D.
員工
3946
國家
US
ISIN
US4579852082
WKN
000897013

上市公司